Evidence map›Paper›PMID 21490922›Full record

ArticlePloS one2011

IKKβ regulates the repair of DNA double-strand breaks induced by ionizing radiation in MCF-7 breast cancer cells.

Lixian Wu, Lijian Shao, Ningfei An, Junru Wang, Senthil Pazhanisamy, Wei Feng, Martin Hauer-Jensen, Shigeki Miyamoto, Daohong Zhou

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting IκappaB kinases for cancer therapy.Seminars in cancer biology · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner.Journal of thrombosis and haemostasis : JTH · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Lixian WuDivision of Radiation Health, Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Lijian Shao
Ningfei An
Junru Wang
Senthil Pazhanisamy
Wei Feng
Martin Hauer-Jensen
Shigeki Miyamoto
Daohong Zhou
University of Arkansas for Medical Sciences · USCentral Arkansas Veterans Healthcare System · USFujian Medical University · CNMedical University of South Carolina · USUniversity of Wisconsin–Madison · US

Funding

Regulation of NEMO modifications in radiation-induced NF-kB signalingR01CA077474 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2000 to 2014
$4.0M
Cancer Therapy-induced Long-term Bone Marrow InjuryR01CA122023 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2007 to 2018
$3.1M
Role of p38 MAPK in HSC Self-Renewal and Radiation-Induced Bone Marrow InjuryR01AI080421 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2008 to 2012
$1.8M
Regulation of NF-kappaB by Small Ubiquitin-Like ModifiersR01GM083681 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2010 to 2013
$1.1M
RADIATION-INDUCED LYMPHOID AND HEMATOPOIETIC TOXICITYR01CA086860 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2000 to 2011
$1.1M
D609-A novel cytoprotectant &selective antitumor agentR01CA102558 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZHOU, DAOHONG · 2004 to 2007
$1.0M
NCI NIH HHS CA102558NCI NIH HHS R01 CA077474NCI NIH HHS R01CA086688NCI NIH HHS R01 CA086860NCI NIH HHS R01 CA102558NCI NIH HHS R01 CA122023NIAID NIH HHS AI080421NIAID NIH HHS R01 AI080421NIGMS NIH HHS R01 GM083681
6 · The paper itself

Abstract

Activation of the IKK-NFκB pathway increases the resistance of cancer cells to ionizing radiation (IR). This effect has been largely attributed to the induction of anti-apoptotic proteins by NFκB. Since efficient repair of DNA double strand breaks (DSBs) is required for the clonogenic survival of irradiated cells, we investigated if activation of the IKK-NFκB pathway also regulates DSB repair to promote cell survival after IR. We found that inhibition of the IKK-NFκB pathway with a specific IKKβ inhibitor significantly reduced the repair of IR-induced DSBs in MCF-7 cells. The repair of DSBs was also significantly inhibited by silencing IKKβ expression with IKKβ shRNA. However, down-regulation of IKKα expression with IKKα shRNA had no significant effect on the repair of IR-induced DSBs. Similar findings were also observed in IKKα and/or IKKβ knockout mouse embryonic fibroblasts (MEFs). More importantly, inhibition of IKKβ with an inhibitor or down-regulation of IKKβ with IKKβ shRNA sensitized MCF-7 cells to IR-induced clonogenic cell death. DSB repair function and resistance to IR were completely restored by IKKβ reconstitution in IKKβ-knockdown MCF-7 cells. These findings demonstrate that IKKβ can regulate the repair of DSBs, a previously undescribed and important IKKβ kinase function; and inhibition of DSB repair may contribute to cance cell radiosensitization induced by IKKβ inhibition. As such, specific inhibition of IKKβ may represents a more effective approach to sensitize cancer cells to radiotherapy.

Indexed as

Radiation, IonizingAnimalsBlotting, WesternCell Line, TumorCells, CulturedDNA Breaks, Double-StrandedDNA RepairFibroblastsHumansI-kappa B KinaseImidazolesMiceMice, KnockoutPolymerase Chain ReactionQuinoxalinesRNA, Small Interfering4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxalineI-kappa B KinaseImidazolesQuinoxalinesRNA, Small Interfering

Identifiers

PMID21490922
PMCPMC3072401
OpenAlexW2073378425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.